Consultant in Metabolic Medicine & Honorary Research Fellow
Shivani is a Consultant in Metabolic Medicine at Imperial College Healthcare NHS Trust and an Honorary Research Fellow within Imperial College. She is an NIHR Clinical Champion in Diabetes Stratified Medicine and has been awarded a Future Leader Mentorship from the European Federation for the Study of Diabetes (2017).
She leads the MY DIABETES study, which recruits at over 40 sites around England and phenotypes young-onset diabetes in different ethnic groups. Her core research interest focuses on stratifying young-onset diabetes using biomarkers and genetics to improve treatment and identification of young-onset diabetes types.
Her other research interests include the detection of monogenic diabetes (MODY), ketosis-prone type 2 diabetes, the use and development of diabetes related biomarkers and laboratory testing guidelines.
Shivani was an NIHR Academic Clinical Fellow in metabolic medicine & chemical pathology and completed a PhD in the Section of Diabetes, Endocrinology & Metabolism, funded by a Sutherland-Earl Clinical Research Fellowship from the Diabetes Research and Wellness Foundation. She has trained in diabetes, clinical biochemistry and laboratory medicine and is a Fellow of the Royal College of Pathologists and Member of the Royal College of Physicians.
Shivani actively participants in undergraduate and postgraduate teaching programmes at Imperial College including supervision of BSc and MRes projects.
et al., 2020, Hyperinsulinemic hypoglycemia in children and adolescents: Recent advances in understanding of pathophysiology and management., Rev Endocr Metab Disord
et al., 2020, Homozygous hypomorphic HNF1A alleles are a novel cause of young-onset diabetes and result in sulphonylurea sensitive diabetes, Diabetes Care, ISSN:0149-5992
et al., 2019, Metabolic health and vascular complications in type 1 diabetes, Journal of Diabetes and Its Complications, Vol:33, ISSN:1056-8727, Pages:634-640
et al., 2019, Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis, Diabetes Research and Clinical Practice, Vol:155, ISSN:0168-8227
et al., 2019, Development of the Point-of-Care Key Evidence Tool (POCKET): a checklist for multi-dimensional evidence generation in point-of-care tests, Clinical Chemistry and Laboratory Medicine, Vol:57, ISSN:1434-6621, Pages:845-855